Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 3 Breast 1

Conditions

Triple Negative Breast Neoplasms 1 Breast Neoplasms 1

Interventions

Paclitaxel 31 Cyclophosphamide 25 Trastuzumab 23 Doxorubicin 17 Docetaxel 15 Carboplatin 15 pembrolizumab 13 Radiotherapy 11 Letrozole 11 Capecitabine 11 exemestane 10 Fulvestrant 10 Magnetic Resonance Spectroscopy 8 Lapatinib 8 Biopsy 8 eribulin 7 abemaciclib 7 Taxes 7 Bevacizumab 7 Anastrozole 7 pertuzumab 6 palbociclib 6 Neoadjuvant Therapy 6 Goserelin 6 Drug Therapy 6 Aromatase Inhibitors 6 130-nm albumin-bound paclitaxel 6 Therapeutics 5 Saline Solution 5 Radiosurgery 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × parsaclisib × Breast × Clear all

NCT04142554 2020-11-03

LCCC1820

UNC Lineberger Comprehensive Cancer Center

Phase 1 Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡